Bioavailable 25(OH)D level is associated with clinical outcomes of patients with diffuse large B-cell lymphoma: An exploratory study

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

Bertrand Coiffier, Catherine Thiéblemont, Éric Van Den Neste et al. · Blood · 2010 · 1.6K citations · Full text

Medicine, Hematology, Oncology +10

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Laurie H. Sehn, Brian Berry, Mukesh Chhanabhai et al. · Blood · 2006 · 1.5K citations

Medicine, Hematology, Oncology +5

Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation

Sheng Chen, Shun‐le Chen, Peter E. Lipsky · The Journal of Immunology · 2007 · 1.1K citations · Full text

Life Sciences, Biochemistry, Immunology +17

Vitamin D–Binding Protein and Vitamin D Status of Black Americans and White Americans

Camille E. Powe, Michele K. Evans, Julia Wenger et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text

Medicine, Nutrition, Nutritional Sciences +14

An Endocytic Pathway Essential for Renal Uptake and Activation of the Steroid 25-(OH) Vitamin D3

Duska Dragun, Diego J. Walther, Henrik Vorum et al. · Cell · 1999 · 1K citations · Full text

Medicine, Biochemistry, Endocrinology +16